Showing results (2261-2270 of 2,466) with videos related to
Sort By:
Pageof 247
Therapie|July 13, 2020
[Summary of the recommendations of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) on the therapeutic drug monitoring of tacrolimus]Florian Lemaitre, Caroline Monchaud, Jean-Baptiste Woillard, et al.Therapie|July 16, 2020
Challenges of autoimmune rheumatic disease treatment during the COVID-19 pandemic: A reviewLucile Grange, Philippe Guilpain, Marie-Elise Truchetet, et al.Therapie|July 27, 2020
Evolution of clotting factor concentrates prescriptions and impact of recommendations of prophylaxis in children with haemophiliaFlorianne Bel, Sandrine Meunier, Anne Lienhart, et al.Therapie|April 3, 2023
Monitoring the safety of drugs and COVID-19 vaccines by the French Pharmacovigilance Centers during the pandemic: A win-win bet with Health Authorities!Annie Pierre Jonville-Bera, Sophie Gautier, Joëlle Micallef, et al.Therapie|April 10, 2021
Characteristics of insulinopenic and non insulinopenic diabetes related to immune checkpoint inhibitors: A French pharmacovigilance studyMarie Bastin, Marion Allouchery, Marion Sassier, et al.Therapie|October 22, 2008
Generics and substitution modalities: proposed methods for the evaluation of equivalence, traceability and pharmacovigilance reportingVéronique Lamarque, Louis Merle, Jean Paul Demarez, et al.Therapie|October 22, 2008
[Setting up of a Clinical Research Centers Ethics Committee in Rhône-Alpes-Auvergne district]Séverine Chomel de Varagnes, Christian Duale, Claude Dubray, et al.Therapie|September 7, 2007
The conduct of clinical trials for medicinal products in europe in the light of the European clinical trials directive. Review of regulatory and practical aspects in the different countriesClaude Dubray, Patricia Maillere, Alain Spriet, et al.Therapie|September 7, 2007
Integrity of scientific data: transparency of clinical trial dataNicholas Moore, Yves Juillet, Pierre-Henri Bertoye, et al.Pageof 247